Tanaka T, Zhong J, Iqbal K, Trenkner E, Grundke-Iqbal I
Osaka Medical School, Department of Psychiatry, Japan.
FEBS Lett. 1998 Apr 17;426(2):248-54. doi: 10.1016/s0014-5793(98)00346-9.
In Alzheimer disease brain the microtubule associated protein (MAP) tau is abnormally hyperphosphorylated. The role of protein phosphatases (PP) in the regulation of phosphorylation of tau was studied in undifferentiated SY5Y cells. In cells treated with 10 nM okadaic acid (OA), a PP-2A/PP-1 inhibitor, the PP-1 and -2A activities decreased by 60% and 100% respectively and the activities of MAPKs, cdc2 kinase and cdk5, but not of GSK-3, increased. OA increased the phosphorylation of tau at Thr-231/Ser-235 and Ser-3961404, but not at Ser-262/356 or Ser-199/202. An increase in tyrosinated/detyrosinated tubulin ratio, a decrease in the microtubule binding activities of tau, MAP1b and MAP2, and cell death were observed. Treatment with 1 microm taxol partially inhibited the cell death. These data suggest (1) that OA induced hyperphosphorylation of tau is probably the result of activated MAPK and cdks in addition to decreased PP-2A and PP-1 activities and (2) that in SY5Y cells the OA induced cell death is associated with a decrease in stable microtubules.
在阿尔茨海默病患者的大脑中,微管相关蛋白(MAP)tau发生异常的高度磷酸化。在未分化的SY5Y细胞中研究了蛋白磷酸酶(PP)在调节tau磷酸化中的作用。在用10 nM冈田酸(OA)(一种PP - 2A/PP - 1抑制剂)处理的细胞中,PP - 1和 - 2A的活性分别降低了60%和100%,丝裂原活化蛋白激酶(MAPKs)、细胞周期蛋白依赖性激酶2(cdc2激酶)和细胞周期蛋白依赖性激酶5(cdk5)的活性增加,但糖原合成酶激酶3(GSK - 3)的活性未增加。OA增加了tau在苏氨酸 - 231/丝氨酸 - 235和丝氨酸 - 396/404处的磷酸化,但在丝氨酸 - 262/356或丝氨酸 - 199/202处未增加。观察到酪氨酸化/去酪氨酸化微管蛋白比率增加、tau、微管相关蛋白1b(MAP1b)和微管相关蛋白2(MAP2)的微管结合活性降低以及细胞死亡。用1 μM紫杉醇处理可部分抑制细胞死亡。这些数据表明:(1)OA诱导的tau高度磷酸化可能是除PP - 2A和PP - 1活性降低外,MAPK和cdk激活的结果;(2)在SY5Y细胞中,OA诱导的细胞死亡与稳定微管的减少有关。